This Article Figures Only Full Text Full Text (PDF) Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fuentes, M A Articles by Miles, K A Search for Related Content PubMed PubMed Citation Articles by Fuentes, M A Articles by Miles, K A

Hepatic haemodynamics: interrelationships between contrast enhancement and perfusion on CT and Doppler perfusion indices

¹Southern X-ray Clinics, 2nd Floor, Day Centre, The Wesley Hospital, 451 Coronation Drive, Auchenflower, Queensland 4066 and ²Centre for Medical, Health and Environmental Physics, Queensland University of Technology, 2 George Street, Brisbane, Queensland 4000, Australia

Correspondence: Dr C Keith

This study compares three techniques that evaluate hepatic haemodynamics for the detection of metastatic liver disease to determine the interrelationships between the techniques and to assess their equivalence. The three techniques studied were dedicated CT measurements of hepatic enhancement, CT measurements of perfusion and Doppler perfusion indices. 53 patients with proven malignancies of either breast or colon underwent a single location dynamic CT for measurement of hepatic perfusion and enhancement, whilst a subset of 12 patients underwent both CT perfusion and Doppler perfusion studies. Statistically significant correlations were found between CT arterial phase enhancement and CT arterial perfusion (r=0.612, p<0.001), and between both of these parameters and Doppler arterial flow (r=0.867, p<0.001 and r=0.842, p<0.001, respectively). Significant correlations were also found between both the ratio of CT arterial enhancement to peak enhancement and the CT arterial perfusion with the Doppler perfusion index (r=0.797, p=0.002 and r=0.725, p=0.008, respectively). Combined CT arterial and portal perfusion correlated with peak liver enhancement (r=0.614, p< 0.001), but Doppler measurements of portal flow did not correlate with any CT parameter. Increased arterial enhancement, perfusion or flow are valuable additional radiological signs for the presence of hepatic metastases that can be elicited by incorporating any one of these methods into existing imaging protocols.

This article has been cited by other articles:

				P S MURPHY, T J McCARTHY, and A S K DZIK-JURASZ The role of clinical imaging in oncological drug development Br. J. Radiol., September 1, 2008; 81(969): 685 - 692. [Abstract] [Full Text] [PDF]

				A. X. Zhu, N. S. Holalkere, A. Muzikansky, K. Horgan, and D. V. Sahani Early Antiangiogenic Activity of Bevacizumab Evaluated by Computed Tomography Perfusion Scan in Patients with Advanced Hepatocellular Carcinoma Oncologist, February 1, 2008; 13(2): 120 - 125. [Abstract] [Full Text] [PDF]

				S. O. Oktar, C. Yucel, T. Demirogullari, A. Uner, M. Benekli, G. Erbas, and H. Ozdemir Doppler sonographic evaluation of hemodynamic changes in colorectal liver metastases relative to liver size. J. Ultrasound Med., May 1, 2006; 25(5): 575 - 582. [Abstract] [Full Text] [PDF]

				J. C. Miller, H. H. Pien, D. Sahani, A. G. Sorensen, and J. H. Thrall Imaging Angiogenesis: Applications and Potential for Drug Development J Natl Cancer Inst, February 2, 2005; 97(3): 172 - 187. [Abstract] [Full Text] [PDF]

				A Nakashige, J Horiguchi, A Tamura, T Asahara, F Shimamoto, and K Ito Quantitative measurement of hepatic portal perfusion by multidetector row CT with compensation for respiratory misregistration Br. J. Radiol., September 1, 2004; 77(921): 728 - 734. [Abstract] [Full Text] [PDF]